TMCnet News
otcstockexchange.com: MHLI, CHTL, GZGT, ACTC - OTCStockExchange.com Stock Alert(M2 PressWIRE Via Acquire Media NewsEdge) RDATE:20082008 Rochester, NY -- OTCStockExchange.com's "Stock Watch Alert" this morning are Marshall Holdings International, Inc. (OTCBB: MHLI), ChinaTel Group, Inc. (OTCBB: CHTL), Guangzhou Global Telecom Inc. (OTCBB: GZGT), Advanced Cell Technology, Inc. (Pink Sheets: ACTC). Sign-up for our FREE Stock Alerts at http://www.otcstockexchange.com ! Marshall Holdings International, Inc. (OTCBB: MHLI - http://finance.yahoo.com/q?s=MHLI.OB ) (Tue, Aug 19, 2008, 8:30am ET) Marshall Holdings announced that distribution of the energy product Socko has expanded to Mexico with the opportunity to place the product into 5,000 available stores over the next year. Elwood Sprenger, Chairman of the Board, said, "Socko Brand Flavored profiles have been well received in the initial test market in Mexico. Mexico is one of the largest consumers of beverages in the world and has more than 750,000 retail accounts. We are looking forward to intelligently building the brand South of the Border and developing meaningful market share, over the next 12 to 36 months, which is anticipated to generate millions in sales revenues." Additional information can be found at: www.marshalldc.com or www.MHII.net ChinaTel Group, Inc. (OTCBB: CHTL - http://finance.yahoo.com/q?s=CHTL.OB ) (Tue, Aug 19, 2008, 8:00am ET) ChinaTel Group, Inc. ("ChinaTel") is pleased to announce today that it has been notified by its counsel and CECT-Chinacomm Communications Co., Ltd. ("ChinaComm") that the 3.5GHz spectrum licenses have been renewed for a term of five years for all 29 cities in the People's Republic of China. ChinaComm holds government licensing to operate a 3.5GHz wireless broadband network across 29 domestic top tier cities encompassing a population of over 300 million persons representing approximately 50% of the overall GDP of China. Guangzhou Global Telecom Inc. (OTCBB: GZGT - http://finance.yahoo.com/q?s=GZGT.OB ) (Tue, Aug 19, 2008, 8:30am ET) Guangzhou Global Telecom Inc., a mobile phone handset, pre-paid calling card distributor and provider of value-added mobile services in the PRC, reported $8,745,541 in 2nd Quarter revenues as compared to $4,789,850 during the same period ended in 2007, representing an increase of $3,955,691 or 83%. Revenues for this year were $16,417,968 as compared to $8,552,268 for the same period in 2007, a jump of almost 100% and a clear indicator of the company's ongoing market expansion. Gross profit increased from $265,248 during the three months ended June 30 2007 to $848,458 in the same period of 2008. The increase of gross profit is mainly generated from the increased revenue. Meanwhile, the gross margin saw a marked improvement from 6% during the quarter ended June 30, 2007 to 10%. Continued focus and initiatives on sales expansion, together with certain rebates, contributed to the higher margins. General and administrative expenses were $254,091 as compared to $223,105 for the same period ended in 2007, an increase of 15%. The increase is consistent with the expansion in operations. Operating profit of $594,367 was recorded during the three months ended March 31, 2008, as compared to a gain of $42,143 during the same period in 2007. The steep increase was the result of improved revenues, gross margins, management policies and programmes put in place. Interest expenses of $59,320 during the three months ended June 30, 2008, which mainly included the interest payment of convertible debt. Net gain of $502,355 was recorded during the three months ended June 30, 2008, as compared to a profit of $16,122 during the same period in 2007. The year-on-year performance saw an increase of $57,062 from $28,536 to $85,598. The strong profit gain for Q2 helped offset losses in Q1. The company's rapid expansion in different regions of China benefited the quarter's data revenue and profit growth and this growth will stay for the year. The focus will not only be on expansion, but also measures such as cost reduction and retaining market presence. The company is constantly seeking to enlarge its customer base and network, placing extra importance on the growing affluence of the middle class in China. The six months of 2008 added more than 45 million mobile subscribers, based on government data. This growth figure continues to be the main driver behind the company's rapid expansion in China. ''Considering this more challenging operating environment, we have fulfilled expectations with our improved financial figures in Q2. We will continue to see strong growth across the set of financial data for the year and our management has developed strategic plans for the mid-long term in facing with rising costs. As 3G technology begins to enter the market, we will experience a new trend in mobile phones usage. This is a new market segment which we are looking at and the recent acquisition of Guangzhou Ren Wo Xing not only provides an equipped platform, it also enlarges our mobile communications market presence in the Guangdong province. Our outlook for the mobile industry remains positive and Guangzhou Global Telecom will look to continue and improve on this quarter's performance,'' commented CEO Li Yankuan. Advanced Cell Technology, Inc. (Pink Sheets: ACTC - http://finance.yahoo.com/q?s=actc.pk ) (Tue, Aug 19, 2008, 3:09pm ET) Advanced Cell Technology, Inc. ("ACT") reported that it is feasible to differentiate and mature human embryonic stem cells (hESCs) into functional oxygen-carrying red blood cells (RBCs) under conditions suitable for scale-up. The research, which appears online (pre-published ahead of print) in the journal Blood -the leading publication in the field --by ACTC and its collaborators at the Mayo Clinic and the University of Illinois, shows for the first time that the oxygen-carrying capacity of hESC-derived blood cells is comparable to normal transfusable RBCs, and that the cells respond to biochemical changes in a physiologically effective manner. "Limitations in the supply of blood can have potentially life-threatening consequences for patients with massive blood loss," said Robert Lanza, M.D., Chief Scientific Officer at ACT, and senior author of the study. "Embryonic stem cells represent a new source of cells that can be propagated and expanded indefinitely, providing a potentially inexhaustible source of red blood cells for human therapy. We can currently generate 10 to 100 billion red blood cells from a single six-well plate of stem cells. The identification of a stem cell line with "O -" blood-type would permit the production of compatible "universal donor" blood. We also have work underway to generate reprogrammed (iPS) stem cells from individuals with universal-donor blood." The efficient and controlled differentiation of hESCs into homogeneous RBC populations has not been previously achieved. This paper describes for the first time the generation of RBCs from hESCs with oxygen-transporting capacity, and that the functional properties of these cells are similar to those of normal erythrocytes. Multiple stem cell lines were stimulated to undergo differentiation in vitro to form functional RBCs (blood types A, B, O, and both RhD+ and RhD-) on a large scale under conditions suitable for scale-up and clinical translation. Although alternative sources of progenitors for the generation of large-scale transfusable RBCs have been investigated, including cord blood, bone marrow and peripheral blood, it is clear that even after expansion and differentiation, these sources represent donor-limited sources of RBCs. Moreover, the low prevalence of O(-) type blood in the general population further intensifies the consequences of blood shortages for emergency situations and battlefield trauma care, where the need for blood typing can imposes serious delays in initiating transfusions Another critical issue for clinical utilization of hESC-derived RBCs is whether they can be enucleated in vitro. "We show that up to 65% of the blood cells underwent multiple maturation events that resulted in the extrusion of the nucleus," stated Shi-Jiang Lu, Ph.D., Director of Differentiation at ACT and first author of the paper. "They formed enucleated erythrocytes with a diameter of 6-8 m, which is similar to normal red blood cells. We also showed that the cells could express adult -globin and respond normally to biochemical changes." "We believe this breakthrough could potentially benefit many Americans," stated William M. Caldwell, CEO and Chairman of ACTC. "Although more work is required before this can move into the clinic, we are pleased with the rapid progress that is being made by our scientists and others. We are optimistic about the potential future role for stem cells as a donorless source of blood for transfusion" The researchers of the paper from Advanced Cell Technology collaborated with scientists from the University of Illinois at Chicago, and the Mayo Clinic, Rochester, Minnesota. The paper's other authors are Qiang Feng and Jennifer Park of ACT, Loyda Vida, Bao-Shiang Lee, and George Honig at the University of Florida, and Michael Strausbauch and Peter Wettstein at the Mayo Clinic. About OTCStockExchange.com OTCStockExchange.com (OTCS) is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. OTCS is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. OTCS's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. OTCS provides all investors with the latest news, press releases, investment opinions, and research reports for all the companies highlighted on the site. OTCS offers a free financial newsletter. To subscribe or get more information, visit our home page located at http://www.otcstockexchange.com . We offer many investor relations programs to public companies. To feature a company on our web site or in our daily Newsletter or Mid-Day Stock Alert, please contact Chris Wheeler at 585-330-8514 , or via email at [email protected] . OTCS's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Affiliates of the publisher for OTCS are to receive a fee of 200,000 shares of Marshall Holdings International, Inc. (MHLI) from Expedite Ventures Inc. for this investment opinion feature. OTCS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. OTCStockExchange.com (OTCS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by OTCS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. OTCS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.otcstockexchange.com or mentioned herein. OTCS has been compensated by third party shareholders or with cash from the company on behalf of one or more of the companies mentioned in this opinion. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and OTCS undertakes no obligation to update such statements. CONTACT: Chris Wheeler, OTCStockExchange.com Tel: +1 585 330 8514 e-mail: [email protected] WWW: http://www.otcstockexchange.com ((M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to [email protected])). Copyright ? 2008 M2 Communications Ltd. |